ABLE Financial Group LLC Increases Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

ABLE Financial Group LLC grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,016 shares of the company’s stock after purchasing an additional 2,692 shares during the quarter. ABLE Financial Group LLC’s holdings in HealthEquity were worth $1,638,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Motley Fool Asset Management LLC raised its stake in shares of HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock worth $307,097,000 after buying an additional 3,640,748 shares during the period. Mackenzie Financial Corp raised its stake in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after acquiring an additional 325,906 shares during the period. Generate Investment Management Ltd purchased a new position in HealthEquity during the second quarter valued at approximately $24,184,000. Thrivent Financial for Lutherans boosted its position in shares of HealthEquity by 924.2% in the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after purchasing an additional 198,718 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of HealthEquity by 1.7% in the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock worth $715,783,000 after purchasing an additional 149,133 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of analyst reports. Bank of America lowered their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reissued a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $103.83.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the sale, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Price Performance

HQY stock traded down $0.11 during trading on Friday, hitting $97.09. 87,078 shares of the company’s stock traded hands, compared to its average volume of 613,340. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $99.57. The stock has a market capitalization of $8.48 billion, a price-to-earnings ratio of 81.00, a P/E/G ratio of 1.36 and a beta of 0.52. The business has a fifty day simple moving average of $82.77 and a 200 day simple moving average of $80.31. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. As a group, research analysts expect that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.